OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
McDonnell Boehnen Hulbert & Berghoff LLP
Kevin Noonan is partner at McDonnell Boehnen Hulbert & Berghoff LLP and chair of the firm’s biotechnology and pharmaceuticals practice group.
Proposed changes to rules governing the commercialization of technologies developed with federal funding prompts significant stakeholder feedback.
Cell-based therapies are moving medical treatments forward, but intellectual property uncertainties may delay progress.